Humacyte, Inc. Common Stock

HUMA XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

170M

Short interest (Jul 15)

12.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

6.07%

↓ 16.4%

Available Shares

↑ 1.0%

Price Chart

Company Overview

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001818382

Asset Type: CS

Market Data

Market Cap: $168,469,919

Employees: 184

Status: Active

Short Interest

Current Borrow Fee 6.07%

Range: 6.07% - 6.07%

Available Shares 7M

Range: 5.7M - 7M

Recent Changes

Fee Change: ↓ 0.3%

Available Change: ↑ 20.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime